MediciNova(MNOV) - 2025 Q4 - Annual Results

Exhibit 99.1 February 20, 2026 Unaudited Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (Under U.S. GAAP) | Company name: | Medicinova, Inc. | | | --- | --- | --- | | Listing: | Tokyo Stock Exchange | | | Securities code: 4875 | | | | URL: | https://medicinova.jp | | | Representative: | Yuichi Iwaki, Representative Director, President and CEO | | | Inquiries: | Kazuko Matsuda, Director and CMO, Vice President, Representative of the Tokyo Office | | | Telephone: | +81-3-5532-5912 ...